|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: FDA (1997)) |
IUPAC Name ![]() |
| 1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 6911 | imiquimod |
Synonyms ![]() |
| Aldara® |
| R837 |
| S-26308 |
| Zyclara® |
Database Links ![]() |
|
| CAS Registry No. | 99011-02-6 |
| ChEBI | CHEBI:36704 |
| ChEMBL Ligand | CHEMBL1282 |
| DrugBank Ligand | DB00724 |
| PubChem CID | 57469 |
| RCSB PDB Ligand | 6T0 |
| Search Google for chemical match using the InChIKey | DOUYETYNHWVLEO-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | DOUYETYNHWVLEO |
| Search PubMed clinical trials | imiquimod |
| Search PubMed titles | imiquimod |
| Search PubMed titles/abstracts | imiquimod |
| Wikipedia | Imiquimod |
| Comments |
| Imiquimod is a TLR7 agonist acting as an immunomodulator. |